Molecular Pituitary Imaging Using 18F-FET PET
The goal of this single centre pilot study is to explore whether 18F-fluoro-ethyl-tyrosine PET (FET-PET) yields comparable findings to 11C-methionine PET (Met-PET) for the localisation of pituitary tumours.
| Condition(s) | Pituitary Adenoma |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | The goal of this single centre pilot study is to explore whether 18F-fluoro-ethyl-tyrosine PET (FET-PET) yields comparable findings to 11C-methionine PET (Met-PET) for the localisation of pituitary tumours. |
| Who can participate | Inclusion criteria * Participant is willing and able to give informed consent for participation in the study * Male or female, age 18 or above * Presence of pituitary adenoma suspected on the basis of clinical/biochemical and/or radiological findings * Previous 11C-Met-PET/CT Exclusion criteria * Inability to give informed consent * Pregnancy or suspected pregnancy * Inability to lie supine for 30-60 minutes * Patient body habitus above scanner dimensions * Known allergy to intravenous radiographic contrast agents |
| Ages | 18 Years to 100 Years |
| Sex | All |
| Lead sponsor | University of Cambridge |
| Locations | Cambridge, Cambridgeshire, United Kingdom |
| Start date | 2024-09-03 |
| NCT ID | NCT06584123 |
| Official listing | https://clinicaltrials.gov/study/NCT06584123 |